MedTrace Logo

Effects of Docosahexaenoic Acid (DHA) on Cardiovascular Disease on Diabetic Patients

NCT01150292 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-05-28

No results posted yet for this study

Summary

Aim: to determine the effects of DHA supplementation:

* on the platelet function through their aggregation and the pathway of arachidonic acid metabolism
* on redox status on cells and plasma
* on inflammation in 16 type 2 diabetic patients in a cross-over study comparing DHA (400 mg/day for 2 weeks) vs Sunflower oil (placebo). Each period is separated by a wash-out period of 6 to 9 weeks.

Conditions

Interventions

DIETARY_SUPPLEMENT

First period DHA

400 mg DHA supplementation by day for 2 weeks during the first study period

DIETARY_SUPPLEMENT

Second period DHA

400 mg DHA supplementation by day for 2 weeks during the second study period

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Martine LAVILLE, MD, PhD · Hospices Civils de Lyon

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01150292 on ClinicalTrials.gov